Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 70-78

  Hamidi, M ^a   Zarei, N ^a   Zarrin, A H ^a   Mohammadi Samani, S ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bovine serum albumin; Carrier erythrocytes; Cellular carriers; Hypotonic preswelling; Vaccine delivery

Indexed keywords

BOVINE SERUM ALBUMIN; DRUG CARRIER; VACCINE;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL SIZE; CYTOLYSIS; DRUG DELIVERY SYSTEM; DRUG RELEASE; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PARAMETER; PARTICLE SIZE; PRIORITY JOURNAL;

ADULT; DRUG CARRIERS; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; HEMOGLOBINS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; OSMOTIC FRAGILITY; PARTICLE SIZE; SERUM ALBUMIN, BOVINE; VACCINES;

EID: 34248661565     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.025     Document Type: Article

References (45)

1. Al-Achi A., and Boroujerdi M. Pharmacokinetics and tissue uptake of doxorubicin associated with erythrocyte-membrane: erythrocytes-ghosts vs. erythrocytes-vesicles. Dev. Ind. Pharm. 16 (1990) 2199-2219
2. Alpar H.O., and Lewis D.A. Therapeutic efficacy of asparaginase encapsulated in intact erythrocytes. Biochem. Pharmacol. 34 (1985) 257-261
3. Babiuk S., Baca-Estrada M., Babiuk L.A., Ewen C., and Foldvari M. Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery. J. Controlled Release 66 (2000) 199-214
4. Banker G.S., and Rhodes C.T. Modern Pharmaceutics (2002), Marcel Dekker Inc., New York
5. Bird J., Best R., and Lewis D.A. The encapsulation of insulin in erythrocytes. J. Pharm. Pharmacol. 35 (1982) 246-247
6. Chia H.H., Yang Y.Y., Chung T.S., Ng S., and Heller J. Auto-catalyzed poly (ortho ester) microspheres: a study of their erosion and release mechanism. J. Controlled Release 75 (2001) 11-25
7. Coombes A.G.A., Lavelle E.C., Jenkins P.G., and Davis S.S. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 14 (1996) 1429-1438
8. Erchler H.G., Gasic S., Bauer K., Korn A., and Bacher S. In vivo clearance of antibody-sensitized human carrier erythrocytes. Clin. Pharmacol. Ther. 40 (1986) 300-303
9. Field W.N., Gamble M.D., and Lewis D.A. A comparison of treatment of thyroidectomized rats with free thyroxine and thyroxine encapsulated in erythrocytes. Int. J. Pharm. 51 (1989) 175-178
10. Garin M.I., Lopez R.M., Sanz S., Pinilla M., and Luque J. Erythrocytes as carriers for recombinant human erythropoietin. Pharm. Res. 13 (1996) 869-874
11. Giudice G.D., Podda A., and Rappuoli R. What are the limits of adjuvanticity?. Vaccine 20 (2002) S38-S41
12. Gupta R.K., and Siber G.R. Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13 (1995) 1263-1276
13. Gutierrez Millan C., Zarzuelo Castaneda A., Sayalero Marinero M.L., and Lanao J.M. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis. Blood Cells Mol. Dis. 33 (2004) 132-140
14. Gutierrez Millan C., Sayalero Marinero M.L., Zarzuelo Castaneda A., and Lanao J.M. Enzyme and peptide delivery using erythrocytes as carriers. J. Controlled Release 95 (2004) 27-49
15. Hamidi M., and Tajerzadeh H. Carrier erythrocytes: an overview. Drug Deliv. 10 (2003) 9-20
16. Hamidi M., Tajerzadeh H., Dehpour A.R., Rouini M.R., and Ejtemaee-Mehr S. In vitro characterization of human intact erythrocytes loaded by enalaprilat. Drug Deliv. 8 (2001) 223-230
17. Hoshi S., Saito N., Kusanagi K., Ihara T., and Ueda S. Adjuvant effects of fluoride on oral immunization of chickens. Vet. Immunol. Immunopathol. 63 (1998) 253-263
18. Ihler G.M., Glew R.H., and Schnure F.W. Enzyme loading of erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 70 (1973) 2663-2666
19. Jain S., and Jain N.K. Engineered erythrocytes as a delivery system. Indian J. Pharm. Sci. 59 (1997) 275-281
20. Jain S., Jain S.K., and Dixit V.K. Erythrocytes based delivery of isoniazid: preparation an in vitro characterization. Indian Drugs 32 (1995) 471-476
21. Jain S., Jain S.K., and Dixit V.K. Magnetically guided rat erythrocytes bearing isoniazid: preparation, characterization, and evaluation. Dev. Ind. Pharm. 23 (1997) 999-1006
22. Jaitely V., Kanaujia P., Venkatesan N., Jain S., and Vyas S.P. Resealed erythrocytes: carrier potentials and biomedical application. Indian Drugs 33 (1996) 549-589
23. Jrade M., Villereal M.C., Boynard M., Dufaux J., and Ropars C. Rheological approach to human red blood cell carriers desferrioxamine encapsulation. Adv. Biosci. 67 (1987) 29-36
24. Kinosita Jr. K., and Tsong T.Y. Survival of sucrose-loaded erythrocytes in the circulation. Nature 272 (1978) 258-260
25. Kravtzoff R., Ropars C., Laguerre M., Muh J.P., and Chassaigne M. Erythrocytes as carriers for L-asparaginase. Methodological and mouse in vivo studies. J. Pharm. Pharmacol. 42 (1990) 473-476
26. Kyselova Z., Rackova L., and Stefek M. Pyridoindole antioxidant stobadine protected bovine serum albumin against the hydroxyl radical mediated cross-linking in vitro. Arch. Gerontol. Geriatr. 36 (2003) 221-229
27. Magnani M., Laguerre M., Rossi L., Branchi M., Nintali F., Magnani F., and Ropars C. Acetaldehyde dehydrogenase-loaded erythrocytes as bioreactors for removal of blood acetaldehyde, alcoholism. Clin. Exp. Res. 13 (1989) 849-859
28. Magnani M., Rossi L., Fraternale A., Bianchi M., Antonelli A., Crinelli R., and Chiarantini L. Erythrocyte-mediated delivery of s, peptides and modified oligonucleotides. Gene Ther. 9 (2002) 749-751
29. Murray A.M., Pearson I.F.S., Fairbanks L.D., Chalmers R.A., Bain M.D., and Bax B.E. The mouse immune response to carrier erythrocyte entrapped antigens. Vaccine 24 (2006) 6129-6139
30. O'Hagan D.T., Singh M., and Gupta R.K. Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines. Adv. Deliv. Rev. 32 (1998) 225-246
31. Pitt E., Johnson C.M., Lewis D.A., Jenner D.A., and Offord R.E. Encapsulation of s in intact erythrocytes: an intravenous delivery system. Biochem. Pharmacol. 32 (1983) 3359-3368
32. Powell M.F. Delivery issues in vaccine development. Pharm. Res. 13 (1996) 1777-1785
33. Prausnitz M.R. Quantitative study of molecular transport due to electroporation: uptake of bovine serum albumin by erythrocyte ghosts. Biophys. J. 66 (1994) 1522-1530
34. Qiu B., Stefanos S., Ma J., Lalloo A., Perry B.A., Leibowitz M.J., Sinko P.J., and Stein S. A hydrogel prepared by in situ cross-linking of a thiol-containing poly (ethylene glycol)-based copolymer: a new biomaterial for protein delivery. Biomaterials 24 (2003) 11-18
35. Ramaldes G.A., Deverre J.-R., Grognet J.-M., Puisieux F., and Fattal E. Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin. Int. J. Pharm. 143 (1996) 1-11
36. Rossi L., Serafini S., Pierige F., Antonelli A., Cerasi A., Fraternale A., Chiarantini L., and Magnani M. Erythrocyte-based delivery. Exp. Opin. Deliv. 2 (2005) 311-322
37. Sprott G.D., Tolson D.L., and Patel G.B. Archaeosomes as novel antigen delivery systems. FEMS Microbiol. Lett. 154 (1997) 17-22
38. Storni T., Kundig T.M., Senti G., and Johansen P. Immunity in response to particulate antigen-delivery systems. Adv. Deliv. Rev. 57 (2005) 333-355
39. Summers M.P. Recent advances in delivery. Pharm. J. 230 (1983) 643-645
40. Tajerzadeh H., and Hamidi M. Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes. Drug Dev. Ind. Pharm. 26 (2000) 1247-1257
41. Talwar N., and Jain N.K. Erythrocytes as carrier of primaquin preparation: characterization and evaluation. J. Controlled Release 20 (1992) 133-142
42. Talwar N., and Jain N.K. Erythrocytes as carrier of metronidazole: in vitro characterization. Dev. Ind. Pharm. 18 (1992) 1799-1812
43. Updike S.J., and Wakamiya R.T. Infusion of red blood cell-loaded asparaginase in monkey. Immunologic, metabolic, and toxicologic consequences. J. Lab. Clin. Med. 101 (1983) 5679-5691
44. Zhao Z., and Leong K.W. Controlled delivery of antigens and adjuvants in vaccine development. J. Pharm. Sci. 85 (1996) 1261-1270
45. Zhou S., Liao X., Li X., Deng X., and Li H. Poly-d,l-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J. Controlled Release 86 (2003) 195-205